Pharmacokinetic Study of Tenofovir Disoproxil Fumarate Combined with Rifampin in Healthy Volunteers

Tenofovir disoproxil fumarate (tenofovir DF) was studied in combination with rifampin in 24 healthy subjects in a multiple-dose, open-label, single-group, two-period study. All subjects were given tenofovir DF at 300 mg once a day (QD) from days 1 to 10 (period 1). From days 11 to 20 the subjects re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Droste, J. A. H., Verweij-van Wissen, C. P. W. G. M., Kearney, B. P., Buffels, R., vanHorssen, P. J., Hekster, Y. A., Burger, D. M.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2005
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC547290/
https://ncbi.nlm.nih.gov/pubmed/15673751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.2.680-684.2005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars